How do I read and understand my Prostate Cancer pathology report
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Your Prostate Cancer Pathology Report
Your pathology report is one of the most important documents in your cancer care. It contains detailed information about your cancer that helps your doctors plan treatment and predict how your cancer might behave. Let me walk you through the key components you'll see.
The Core Components of Your Report
1. Gleason Score and Grade Group
This is probably the most critical part of your report. Here's how it works:
What the pathologist does: According to the NCCN Guidelines for Patients, when a pathologist examines your biopsy samples under a microscope, they look at the pattern of cancer cells. A pattern that looks more like normal, healthy cells gets a lower number. A pattern that looks more abnormal gets a higher number. These patterns range from 3 to 5 (patterns 1 and 2 are so rare they're no longer used).
How the Gleason Score is calculated: Since prostate biopsies usually contain more than one pattern of cancer cells, the pathologist combines the two most common patterns:
- The pattern taking up the largest area = first number
- The pattern with the second-largest area = second number
- Add them together = your Gleason score
Example: If your report shows pattern 3 + pattern 4, your Gleason score is 7.
What the score means:
- Gleason 6 = lowest score (cancer looks most like normal tissue)
- Gleason 7 = intermediate-grade (moderate aggressiveness)
- Gleason 8-10 = high-grade (cancer looks very abnormal and is more likely to grow and spread quickly)
Grade Groups (the simpler way to think about it): To make Gleason scores easier to understand, they're organized into Grade Groups:
- Grade Group 1 = Gleason 6
- Grade Group 2 = Gleason 7 (3+4)
- Grade Group 3 = Gleason 7 (4+3)
- Grade Group 4 = Gleason 8
- Grade Group 5 = Gleason 9-10
Why this matters: Your Grade Group helps estimate your cancer risk and guides treatment decisions.
2. Number of Cores with Cancer
Your pathology report will tell you how many of your biopsy samples actually contained cancer. For example, you might see "5 out of 12 cores positive" or "cancer in 7 of 12 samples."
What this means: According to NCCN Guidelines, this information helps your doctor estimate how much cancer is in your entire prostate. If cancer is found in many cores, it suggests more cancer throughout the gland. If only a few cores show cancer, it may be more localized.
3. Percentage of Cancer in Each Core
The report may also describe what percentage of each core sample contains cancer. For example:
- "Core 1: 40% involvement"
- "Core 3: 5% involvement"
What this means: This shows whether the cancer is concentrated in certain areas of your prostate or spread throughout. This information helps your doctor understand the distribution of your cancer.
4. Tumor Stage (TNM Score)
Your pathology report may include staging information based on the biopsy findings. This uses the TNM system:
- T (Tumor) = Size of the main tumor and whether it's grown outside the prostate
- N (Node) = Whether cancer has spread to lymph nodes
- M (Metastasis) = Whether cancer has spread to distant parts of your body
For example, T2, N0, M0 means:
- T2 = tumor is large enough to feel during a digital rectal exam but hasn't grown outside the prostate
- N0 = no spread to lymph nodes
- M0 = no spread to distant sites
5. Genetic and Molecular Testing Results
Modern pathology reports increasingly include molecular biomarker testing. According to the NCCN Guidelines for Advanced Prostate Cancer, your report may show testing for:
- DNA repair genes (BRCA1, BRCA2, ATM, PALB2, FANCA, and others)
- Other genetic mutations that might indicate which treatments could work best
Why this matters: If your cancer has certain mutations, you may be eligible for targeted therapies like PARP inhibitors.
Questions to Ask Your Doctor About Your Pathology Report
According to NCCN Guidelines, here are specific questions that will help you understand your results:
-
"What is my Gleason score and Grade Group, and what does this mean for my cancer risk?"
-
"How many of my biopsy cores contained cancer, and what does this tell you about how much cancer is in my prostate?"
-
"What is my TNM stage, and what does each letter and number mean?"
-
"Were any genetic or molecular tests done on my biopsy? If so, what did they show?"
-
"Based on all these results, what risk group am I in (low, intermediate, or high risk)?"
-
"Can I get a copy of my complete pathology report to keep for my records?"
How Your Pathology Results Guide Treatment Decisions
According to NCCN Guidelines, your pathology results are combined with other information to determine your overall risk group:
- PSA level (blood test)
- Grade Group (from pathology)
- Tumor stage (TNM score)
- Biopsy results (percentage and number of cores with cancer)
Together, these factors help your doctor decide whether you might benefit from:
- Active surveillance (careful monitoring without immediate treatment)
- Surgery (prostatectomy)
- Radiation therapy
- Hormone therapy
- Other treatment combinations
Key Takeaway
Your pathology report is a detailed map of your cancer. The Gleason score and Grade Group tell you how aggressive your cancer appears under the microscope. The number and percentage of positive cores tell you how much cancer is present. Together with your PSA level and imaging results, this information creates a complete picture that guides your treatment plan.
Don't hesitate to ask your doctor to explain any terms or results you don't understand. A good oncologist will take time to review your pathology report with you in detail.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Prostate Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Prostate Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: